Clinical Trials

M6-C™ Artificial Cervical Disc Two-Level IDE Study

March 9, 2022

IRB Approved at the Protocol Level Jul 09, 2021

Now Enrolling Patients in the BAGUERA® C Cervical Disc Replacement Clinical Trial

November 12, 2021

Desert Institute for Spine Care is now enrolling patients in two clinical trials evaluating a new cervical disc replacement option for patients with degenerative cervical disc disease.

The clinical trials are evaluating the BAGUERA® C cervical artificial disc, which is designed to help maintain the natural behavior and mobility of a functional cervical spine. While the BAGUERA C is new in the U.S and only available in these clinical trials, more than 35,000 have been implanted in patients in more than 40 countries outside the U.S. since 2007.


M6-C artificial disc

M6-C Artificial Disc: FDA IDE Pivotal Study

September 19, 2014

Status: This trial has been completed.

Introduction
DISC is one of 12 sites in US, only in AZ where patients have access to the M6-C Artificial Disc: FDA IDE Pivotal Study.  If you are a patient who is interested in participating in this study, please contact DISC directly.

LEADERS IN MINIMALLY INVASIVE SPINE CARE
1635 E. Myrtle • Suite 400 • Phoenix, AZ 85020
Ph: 602-944-2900 • Fax: 602-944-0064

DISC - Desert Institute for Spine Care